Viewing Study NCT02596100


Ignite Creation Date: 2025-12-26 @ 12:16 PM
Ignite Modification Date: 2026-01-13 @ 7:50 AM
Study NCT ID: NCT02596100
Status: COMPLETED
Last Update Posted: 2023-08-08
First Post: 2015-10-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations
Sponsor: Portola Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module